Skip to main content
Signal8
Launch Terminal
Blayney Douglas profile photo

Douglas Blayney

CIK: 0001772396

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)3 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

ARTELO BIOSCIENCES, INC. logo
ARTL

ARTELO BIOSCIENCES, INC.

Director

Discretionary Trading P&L

Holdings

Transaction History (3 total)

  • ARTELO BIOSCIENCES, INC. logo
    ARTL

    ARTELO BIOSCIENCES, INC.

    Jul 17, 2026
    Award(A)

    Stock Option (right to buy)

    Direct
    136 shares-
  • ARTELO BIOSCIENCES, INC. logo
    ARTL

    ARTELO BIOSCIENCES, INC.

    Jan 30, 2026
    Award(A)

    Stock Options (right to buy)

    Direct
    292 shares-
  • ARTELO BIOSCIENCES, INC. logo
    ARTL

    ARTELO BIOSCIENCES, INC.

    Dec 20, 2024
    Award(A)

    Stock Option (right to buy)

    Direct
    1.8K shares-

1-3 of 3

About Blayney Douglas

Blayney Douglas (SEC CIK 0001772396) files insider reports with the SEC as Director of ARTELO BIOSCIENCES, INC. (ARTL).

Signal8 holds 3 ownership filings by Blayney Douglas, all Form 4s, filed between Dec 23, 2024 and Jul 21, 2026. Those filings report 3 transactions, from Dec 20, 2024 to Jul 17, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Blayney Douglas's filings is in SOLANA BEACH, CA.

Recent filings by Blayney Douglas

  • Jul 17, 2026: Grant or award of ARTL derivative securities (Form 4, code A).
  • Jan 30, 2026: Grant or award of ARTL derivative securities (Form 4, code A).
  • Dec 20, 2024: Grant or award of ARTL derivative securities (Form 4, code A).

Other insiders filing for ARTELO BIOSCIENCES, INC. (ARTL)

How to read Form 4 transaction codes